摘要
世界连锁超市巨头沃尔玛推出"4美元廉价仿制药计划",基本解决了低保低收入人群用药难的问题,尤其对老年慢性常见病的治疗发挥了重要作用。而这样的计划在中国是否有推行的必要和可能?
Wal-Mart launches $4 Prescription Program,basically solving the drug use problem of the low-income people and the people with basic living allowances,playing an important role in the treatment of common chronic diseases particularly in senior citizens. Is such a program necessary and possible in China?
出处
《中国处方药》
2010年第11期14-,5+72,共1页
Journal of China Prescription Drug
